Skip to main content

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Bajorin D, Katz A, Chan E, et al: Comparison of criteria for assigning germ cell tumor patients to “good risk” and “poor risk” studies. J Clin Oncol 4:786–792, 1986

    Google Scholar 

  • Birch R, Williams S, Cone A, et al: Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4:400–407, 1986

    PubMed  CAS  Google Scholar 

  • Boyer M, Raghavan D: Toxicity of treatment of germ cell tumors. Semin Oncol 19:128–142, 1992

    PubMed  CAS  Google Scholar 

  • Einhorn LH: Testicular cancer as a model for a curable neoplasm: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 41:3274–3280, 1981

    Google Scholar 

  • Freedman LS, Parkinson MC, Jones WG, et al: Histopathology in the prediction of relapse of patients with Stage I testicular teratoma treated by orchiectomy alone. Lancet 2:294–298, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hoskin P, Dilly S, Easton D, et al: Prognostic factors in Stage I non-seminomatous germ cell tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4:1031–1036, 1986

    PubMed  CAS  Google Scholar 

  • International Germ Cell Cancer Collaborative Group: International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603, 1997

    Google Scholar 

  • Mead GM, Stenning SP, Parkinson MC, et al: The Second Medical Research Council study of prognostic factors in non-seminomatous germ cell tumors. J Clin Oncol 10:85–94, 1992

    PubMed  CAS  Google Scholar 

  • Peckham MJ, Barrett A, McElwain TJ et al: Nonseminoma germ cell tumours (malignant teratoma) of the testis: results of treatment and an analysis of prognostic factors. Br J Urol 53:162–172, 1981

    Article  PubMed  CAS  Google Scholar 

  • Raghavan D, Colls B, Levi J, et al: Surveillance for Stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined. Br J Urol 61:522–526, 1988

    Article  PubMed  CAS  Google Scholar 

  • Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etposide. N Engl J Med 317:1433–1438, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Consortia

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

American Joint Committee on Cancer. (2002). Testis. In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3656-4_35

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-00595-7

  • Online ISBN: 978-1-4757-3656-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics